Onco: Principles of Treatment Flashcards
Indications for use of GCSF (Preventive)
a. Administration of GCSF is routine with the first cycle of chemotherapy
b. Use if the probability of febrile neutropenia >=20%
c. Use if patient has good performace status
d. Use for age >60 years treated for lymphoma with curative intent
e. AOTA
B.
A is wrong. not needed on a routine basis
C. use of patient has poor performance status
D.Age >65 years treated for lymphoma with curative intent
True of secondary CSF administration
a. Done with subsequent cycles if febrile neutropenia has previously occurred
b. Not needed after short-duration neutropenia without fever
c. Use if prolonged neutropenia delays therapy
d. AOTA
e. NOTA
D
True of CSF administration for therapeutic uses
a. There is strong evidence of benefit for administration of CSF in afebrile neutropenic patients
b. There is no evidence of benefit in giving CSF for febrile neutropenic patients.
c. it is safe to give GMCSF in AML
d. AOTA
B.
A is wrong, no strong evidence of benefit
C is wrong, it may cause harm
T/F all cancers present as tumors
F; how about leukemia?
syndrome of Tumor presentation owing to the effects of substances they secrete is called
Paraneoplastic syndrome
Establishing cancer diagnosis is usually accomplished by this procedure
biopsy
Entire tumor mass is removed with a small margin of normal tissue surrounding it, and subsequent pathologic studies.
Excisional biopsy
Wedge of tissue is removed and an effort is made to include the majority of the cross-sectional diameter of the tumor in the biopsy to minimize sampling error. This procedure is called
Incisional biopsy
Excisional biopsy, if possible, is preferred over incisional biopsy. T/F
T
c-kit oncoprotein mutation
a. Breast Cancer
b. Colon cancer
c. melanoma
d. GI stromal tumor
D
Ki-ras mutation
a. Breast CA
b. brain tumor
c. Leukemia
d. Colon cancer
D
Bcr-Abl fusion protein
a. Lymphoma
b. Leukemia
c. Lung cancer
d. brain cancer
B
Alk oncoprotein gene fusion
a. breast cancer
b. lung cancer
c. melanoma
d. brain tumor
B
c-kit expression and mutation
a. GI stromal tumor
b. melanoma
c. leukemia
d. lymphoma
B; GI tumor is c-kit oncoprotein mutation
CD30 immunohistochemistry
a. leukemia
b. lymphoma
c. colon cancer
d. ovarian cancer
B
This biopsy procedure obtains only a suspension of cells from within a mass
fine needle aspiration
This biopsy procedure obtains considerably less tissue, but often provides information to plan a definitive surgical procedure
Core-needle biopsy
T/F it’s safe to say that it’s not cancer when fine needle aspiration is negative
F